SCHEMBL30830771

SCHEMBL30830771

CNCc1ccc(Oc2cccc3c2C(=O)NC3=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 5/20 0.42
▸ SLC6A4 P31645 4/20 0.42
▸ PARP1 P09874 1/20 0.41
▸ HTR7 P34969 4/20 0.39
▸ GAA P10253 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ SLK Q9H2G2 3/20 0.38
▸ STK10 O94804 2/20 0.38
▸ CACNA1B Q00975 2/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ CASP3 P42574 2/20 0.36
▸ KCNH2 Q12809 3/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ HTR1D P28221 1/20 0.36
▸ HTR1B P28222 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ HTR1E P28566 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5506330 0.78 MAOA (0.51) PARP1GAAKDM4EALDH1A1HPGD
SCHEMBL16628857 0.77 MAOA (0.41) PARP1GAAKDM4EALDH1A1HPGD
SCHEMBL9550305 0.77 KCNA5 (0.40) PARP1GAAKDM4EALDH1A1HPGD
SCHEMBL262473 0.76 GSK3B (0.50) PARP1GAAKDM4EALDH1A1HPGD
SCHEMBL28812042 0.75 MAOA (0.59) HPGD
SCHEMBL9768590 0.73 KDM4E (0.51) PARP1GAAKDM4EALDH1A1HPGD
SCHEMBL30830532 0.71 DDB1 (0.64) ALDH1A1
Water SCHEMBL8678456 0.71 DDB1 (0.45) PARP1GAAKDM4EALDH1A1HPGD
SCHEMBL22904147 0.71 MAOB (0.38) CASP3
SCHEMBL8498986 0.70 MAOA (0.50) GAARXFP1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback